Henry E. Mark

Geneve, GE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Assessing Europe's policy readiness to confront the MASLD/MASH public health threat.

Assessing Europe's policy readiness to confront the MASLD/MASH public health threat.

Journal: The Lancet regional health. Europe

Published: December 15, 2025

Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes.

Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes.

Journal: JAMA network open

Published: November 06, 2025

Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine Countries.

Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine Countries.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: August 21, 2025

A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis.

A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis.

Journal: The Lancet regional health. Europe

Published: February 11, 2025

Mpox: Neglect has led to a more dangerous virus now spreading across borders, harming and killing people. Leaders must take action to stop mpox now.

Mpox: Neglect has led to a more dangerous virus now spreading across borders, harming and killing people. Leaders must take action to stop mpox now.

Journal: PLOS global public health

Published: October 17, 2024

Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis.

Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis.

Journal: Gastroenterology

Published: October 07, 2024

Global patterns of utilization of noninvasive tests for the clinical management of metabolic dysfunction-associated steatotic liver disease.

Global patterns of utilization of noninvasive tests for the clinical management of metabolic dysfunction-associated steatotic liver disease.

Journal: Hepatology communications

Published: September 09, 2024

Best buy interventions to address the burden of steatotic liver disease.

Best buy interventions to address the burden of steatotic liver disease.

Journal: The lancet. Gastroenterology & hepatology

Published: July 01, 2024

Political courage needed to prevent the next pandemic.

Political courage needed to prevent the next pandemic.

Journal: Lancet (London, England)

Published: June 14, 2024

Opportunities and challenges following approval of resmetirom for MASH liver disease.

Opportunities and challenges following approval of resmetirom for MASH liver disease.

Journal: Nature medicine

Published: April 19, 2024

The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement.

The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement.

Journal: Hepatology communications

Published: December 01, 2023

Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives.

Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives.

Journal: Journal of hepatology

Published: July 20, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026